Diagnostics & Research Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 63 |  TMO Thermo Fisher Scientific Inc Common Stock | 639.63 USD | -3.35% | -3.58% | +6.06% | +20.12% | 236.50 B USD | ||
| 102 |  DHR Danaher Corporation Common Stock | 213.19 USD | -2.46% | -1.18% | +4.08% | +4.40% | 149.87 B USD | ||
| 291 |  NTRA Natera, Inc. - Common Stock | 384.83 USD | -2.71% | -8.02% | +18.72% | +124.44% | 55.47 B USD | ||
| 325 |  A Agilent Technologies, Inc. Common Stock | 164.60 USD | -2.62% | -2.76% | +13.06% | +16.86% | 46.41 B USD | ||
| 353 |  WAT Waters Corporation Common Stock | 424.34 USD | -2.69% | -1.77% | +5.00% | +28.83% | 41.69 B USD | ||
| 354 |  IQV IQVIA Holdings, Inc. Common Stock | 253.12 USD | -1.94% | -3.81% | -1.58% | +25.20% | 41.66 B USD | ||
| 366 |  IDXX IDEXX Laboratories, Inc. - Common Stock | 510.12 USD | +0.68% | -1.99% | -1.33% | -18.33% | 40.19 B USD | ||
| 374 |  ILMN Illumina, Inc. - Common Stock | 259.55 USD | -3.07% | -4.02% | +23.60% | +165.85% | 39.19 B USD | ||
| 441 |  MTD Mettler-Toledo International, Inc. Common Stock | 1513.47 USD | -1.30% | +1.22% | +16.14% | +14.63% | 30.32 B USD | ||
| 498 |  LH Labcorp Holdings Inc. Common Stock | 310.87 USD | -0.39% | +0.93% | -4.45% | +11.38% | 25.21 B USD | ||
| 501 |  DGX Quest Diagnostics Incorporated Common Stock | 226.93 USD | -0.01% | -2.19% | -2.62% | +25.15% | 25.05 B USD | ||
| 544 |  GH Guardant Health, Inc. - Common Stock | 162.90 USD | -3.23% | -8.86% | +1.18% | +124.50% | 21.86 B USD | ||
| 649 |  RVTY Revvity, Inc. Common Stock | 148.54 USD | -3.25% | -2.80% | +18.28% | +56.59% | 16.58 B USD | ||
| 650 |  MEDP Medpace Holdings, Inc. - Common Stock | 593.28 USD | -1.82% | -2.18% | +0.56% | -2.19% | 16.56 B USD | ||
| 709 |  CRL Charles River Laboratories International, Inc. Common Stock | 290.07 USD | -3.38% | -0.05% | +3.52% | +47.36% | 13.85 B USD | ||
| 772 |  ICLR ICON plc - Ordinary Shares | 162.47 USD | -0.98% | -1.00% | +2.37% | -12.71% | 12.44 B USD | ||
| 908 |  QGEN Qiagen N.V. Common Shares | 44.31 USD | -1.09% | +3.60% | +5.20% | -7.15% | 9.61 B USD | ||
| 923 |  TWST Twist Bioscience Corporation - Common Stock | 150.34 USD | -3.41% | -24.27% | +18.71% | +359.05% | 9.43 B USD | ||
| 1192 |  GRAL GRAIL, Inc. - Common Stock | 129.30 USD | -2.71% | -7.19% | +63.75% | +30.61% | 5.78 B USD | ||
| 1263 |  RDNT RadNet, Inc. - Common Stock | 66.48 USD | -3.10% | -3.19% | -6.77% | -20.30% | 5.23 B USD |
Nachrichten Diagnostics & Research Stocks
Myriad Genetics und SOPHiA GENETICS kooperieren mit AstraZeneca bei Prostatakrebs-Biomarker
SOPHiA GENETICS und Myriad Genetics arbeiten zusammen, um die neue technologie zur genomischen Instabilitätsbewertung speziell für Prostatakrebs voranzutreiben
Dieser Generac-Analyst nimmt die Beobachtung mit einer optimistischen Einschätzung auf; hier sind die 5 wichtigsten Erstbewertungen für Donnerstag
Jefferies nimmt die Bewertung von Twist Bioscience mit der Einstufung „Hold“ auf und gibt ein Kursziel von 150 US-Dollar bekannt
Argenx, Caribou Biosciences und andere große Aktien mit Kursverlusten im vorbörslichen Handel am Donnerstag
Twist Bioscience: Jefferies startet Coverage mit ’Hold’ – Aktie bereits über Kursziel
Charles River Labs: Top-Managerin verkauft Aktien im Wert von 302.579 $
Gainers Diagnostics & Research Stocks
 BIAFW bioAffinity Technologies, Inc. - Warrant | 0.5699 | +60.49% |
 BIAF bioAffinity Technologies, Inc. - Common Stock | 8.01 | +30.03% |
 STRR Star Equity Holdings, Inc. - Common Stock | 10.35 | +6.59% |
 VNRX VolitionRX Limited Common Stock | 0.23 | +4.55% |
 ACRS Aclaris Therapeutics, Inc. - Common Stock | 3.52 | +3.53% |
 NEOG Neogen Corporation - Common Stock | 11.88 | +1.71% |
 XWEL XWELL, Inc. - Common Stock | 0.91 | +1.11% |
IDXX IDEXX Laboratories, Inc. - Common Stock | 510.12 | +0.68% |
